KYMR vs MRNA · rev $99.4M vs rev $145.0M
Kymera Therapeutics Inc (KYMR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
KYMR currently screens at market cap $7.39B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the KYMR and MRNA stock pages for the full models.
Not investment advice.